The Joint Ways and Means Committee on June 26 amended and reported out Senate Bill 844, a broad public-health measure that updates provisions for the Oregon Health Authority, opioid reporting, psilocybin information disclosure, environmental health training, and clinical laboratory requirements.

Representative LaFeldrama introduced SB 844 and said the bill “updates provisions relating to the Oregon Health Authority, opioid and opioid reporting, psilocybin investigations, environmental health and environmental health and wastewater specialist train and training eligibility requirements and clinical laboratory requirements.” The committee adopted a dash B4 conflict amendment to resolve conflicts with House Bill 2387, which the amendment says would control modifications to the statute governing psilocybin information that is exempt from disclosure.

Senator Girod said she would be “a yes on the amendment,” adding wryly that the amendment “makes a really, really bad bill, just a bad bill,” indicating the amendment improved the measure in her view. After brief discussion and no recorded objections in the transcript, the committee reported SB 844 out due pass as amended.

The dash B4 conflict amendment specifies that if HB 2387 becomes law, the modifications to the cited ORS provision under this act are repealed and replaced as specified in HB 2387. The committee’s report-out moves the amended bill to the next legislative stage for floor action and further consideration.